SEC Form 4 · accession 0001209191-15-035360

ZEVRA THERAPEUTICS, INC. · ZVRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Apr 21, 2015

Accepted (ET)

Apr 21, 2015 · 6:50 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001434647

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Apr 21, 2015	C	7,373	—	A	7,373	D
Common Stock^F1,F2,F3	Apr 21, 2015	C	91,687	—	A	91,687	I	By Garrett Bancshares, LTD

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A Convertible Preferred Stock^F2	—	Apr 21, 2015	C	26,355	D	—	—	Common Stock	3,514	D
Series B Convertible Preferred Stock^F2	—	Apr 21, 2015	C	16,129	D	—	—	Common Stock	2,150	D
Series C Convertible Preferred Stock^F2	—	Apr 21, 2015	C	12,820	D	—	—	Common Stock	1,709	D
Series A Convertible Preferred Stock^F3,F2	—	Apr 21, 2015	C	269,959	D	—	—	Common Stock	35,994	I
Series B Convertible Preferred Stock^F3,F2	—	Apr 21, 2015	C	161,290	D	—	—	Common Stock	21,505	I
Series C Convertible Preferred Stock^F3,F2	—	Apr 21, 2015	C	256,410	D	—	—	Common Stock	34,188	I

F1The total represents shares received upon conversion of Series A, Series B and Series C convertible preferred stock.
F2Effective upon the closing of the Issuer's initial public offering of its common stock, each share of Series A, Series B and Series C convertible preferred stock automatically converted into 0.13333 shares of common stock. The convertible preferred stock had no expiration date.
F3The Reporting Person is the Vice-President of Garrett Bancshares, LTD and may be deemed to have shared voting and dispositive power over, and be deemed to be indirect beneficial owner of, the shares directly held by Garrett Bancshares, LTD.